Effect of Fentanyl on Emergence Delirium (ED) on Children Undergoing Adeno-tonsilectomy at Kenyatta National Hospital (KNH)

July 15, 2016 updated by: Dr. Kirwa Elisha kiprono, University of Nairobi

Effect of Fentanyl Given Approximately Ten Minutes to the End of Surgery on Emergence Delirium in Children Undergoing Adeno-tonsilectomy at Kenyatta National Hospital: A Randomized Placebo Controlled Clinical Trial

This study will be a randomized double blind placebo controlled clinical trial among children undergoing adeno-tonsillectomy in KNH. The intervention arm will comprise Fentanyl given at a dose of 1ug/while the placebo arm will be given normal saline at a volume equivalent to Fentanyl dose, treatment will be administered approximately ten minutes to the end of surgery determined by the time when the mouth gag will be removed. The main outcome will be incidence of ED at the recovery room using Watcha scale and secondary outcomes will be delay in emergence time from anaesthesia and effectiveness of fentanyl in preventing ED.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

110

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 12 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • American Society of Anaesthesiologists classes (ASA) 1 and 2 children.

    • ASA 1 - Normal healthy child scheduled for adeno-tonsilectomy.
    • ASA 2 - Child with mild systemic disease without functional limitations.
  • Children aged 1 to 12 years.
  • Children undergoing elective adeno-tonsilectomy.
  • Those children whose parents/guardians have given a written informed consent.

Exclusion Criteria:

  • Children with genetic syndromes.
  • Children with psychological/neurological behavioural disorders.
  • Children with allergies to Fentanyl.
  • Children with psychiatric disorders/ use of psychiatric medications.
  • Use of sedative medications one hour prior to surgery.
  • Children with developmental delay.
  • Children coming in as day case.
  • Children with airway problems not related to the surgery-sleep apnoea.
  • Children less than 1 year and those above 13 years.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Fentanyl group
Fentanyl given at a dose of one micro gram per kilogram body weight
The intervention arm will comprise Fentanyl given at a dose of one microgram per kilogramme body weight administered approximately ten minutes to the end of surgery determined by the time when the mouth gag will be removed.
Other Names:
  • treatment
Placebo Comparator: normal saline group
placebo arm will be given normal saline at a volume equivalent to Fentanyl dose as per body weight.
the placebo arm will be given normal saline at a volume equivalent to Fentanyl dose per body weight,administered approximately ten minutes to the end of surgery determined by the time when the mouth gag will be removed
Other Names:
  • placebo

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The number of patients who develop emergence delirium in both arms
Time Frame: 30 minutes
the number of patients who develop emergence delirium within 30 minutes after general anaesthesia will be assessed using Watcha scale indicated in the study questionnaire,
30 minutes
the local incidence of emergence delirium.
Time Frame: 30 minutes
local incidence of emergence delirium will be determined by the percentage of those who develop emergence delirium in the placebo group within 30 minutes after general anesthesia as assessed by Watcha scale.
30 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the percentage of patients developing emergence delirium in fentanyl group with 30 minutes after general anaesthesia.
Time Frame: 30 minutes
the percentage of patients developing emergence delirium in both groups will be compared to determine if fentanyl prevents emergence delirium.
30 minutes
duration of emergence time from general anaesthesia in minutes
Time Frame: 30 minutes
the time taken to emerge from both arms will be compared to determine if fentanyl delays emergence time from general anaesthesia.
30 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2016

Primary Completion (Actual)

July 1, 2016

Study Completion (Actual)

July 1, 2016

Study Registration Dates

First Submitted

April 11, 2016

First Submitted That Met QC Criteria

April 25, 2016

First Posted (Estimate)

April 28, 2016

Study Record Updates

Last Update Posted (Estimate)

July 18, 2016

Last Update Submitted That Met QC Criteria

July 15, 2016

Last Verified

July 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe